Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Major private payer encouraging employees to leave willingly
The largest Medicaid-specialized managed care organization in the U.S. is offering buyout packages to most of its 60,000 or so staff workers.
‘Epic’ trademark lawsuit leaves healthcare staffing firm without a name
Epic Systems, the market leading EHR vendor, sued California-based Epic Staffing in 2024, arguing that the company’s name created confusion in the market. The lawsuit was settled out of court, with the employment firm agreeing to a full rebrand.
As Americans tuck into supplements like their health depends on it, specialized products are displacing multivitamins
Some of today’s most popular products promise better immune, adaptogenic, anti-inflammatory, gut, skin or joint health—or combinations of two or more of the above.
Express Scripts sues Tennessee over PBM law that would close specialty pharmacy
The company called the state’s regulation of pharmacy benefit managers “shortsighted,” as it would force the closure of Accredo, a specialty drug dispensary that supplies drugs it says aren’t available anywhere else in the state.
FTC settles lawsuit with Optum Rx, ending its campaign against the ‘big three’ PBMs
The agency had been suing the three largest pharmacy benefit managers over their alleged control of insulin prices. It reached agreements with CVS’ Caremark and Cigna’s Express Scripts earlier this year.

CT contrast shortage seen as amplification, continuation of deep-set dynamics

The shortage of iodinated contrast media that has rattled U.S. radiology since early May didn’t come from nowhere.

The GE healthcare vScan Air was one of several point of care ultrasound (POCUS) systems on display at the ACC 2022 meeting.

Scholarly POCUS judges impressed by handheld models from GE, Philips, EchoNous

Two dozen academic physicians from around the U.S. with expertise in point-of-care ultrasound—and no vested interest in POCUS industry players—recently tested and compared four commercially available POCUS handhelds.

Lightweight, short-stature MR scanner cleared

The FDA has greenlit a whole-body MRI machine that uses deep learning and advanced image processing to wring “elevated image quality” from a magnet with only 0.55 Tesla field strength.

Another mammography team in hot water over image quality

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

POCUS access: Urban oases, rural deserts

Fewer than 40% of rural counties in the U.S. can offer residents any access to point-of-care ultrasound, while nearly 90% of their metropolitan counterparts have POCUS aplenty.

MRI confirmed as gold standard for pre-biopsy detection of prostate cancer—but that’s ‘not the end of the story’

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

Low back imaging: All-in-one MR makes strong showing vs. added CT

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

Radiology operation loses standing to provide mammography services

The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.

Business Intelligence

Major private payer encouraging employees to leave willingly

‘Epic’ trademark lawsuit leaves healthcare staffing firm without a name

As Americans tuck into supplements like their health depends on it, specialized products are displacing multivitamins

Express Scripts sues Tennessee over PBM law that would close specialty pharmacy

FTC settles lawsuit with Optum Rx, ending its campaign against the ‘big three’ PBMs